What's happening
This bill creates a psilocybin-assisted therapy pilot program for veterans, first responders, and certain others in western New York.
Why it matters
Provides free access to psilocybin-assisted therapy. for up to 10,000 eligible participants, meaning cost barriers are removed for veterans, first responders, their families, and people with cluster headaches in western New York—groups often facing mental health challenges with limited treatment options.
Establishes strong patient and provider protections. , ensuring that those who participate in the program—including facilitators and patients—are shielded from arrest, prosecution, employment discrimination, and professional disciplinary action solely for their involvement in the certified medical use of psilocybin.
Requires specialized facilitator training. , which helps ensure therapy sessions are conducted safely and effectively by professionals or individuals with relevant experience who complete a state-mandated course.
Mandates ongoing oversight and research. , directing the health department to monitor, evaluate, and report on the program’s outcomes every two years—potentially influencing future policy decisions and expanding access if positive results are demonstrated.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Psilocybin Therapy for Veterans
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 34
2 Co-sponsors
History
- Print number 7832a
- Amend and recommit to health
- Referred to health
- Referred to rules
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Therapy Shrooms for Veterans
In Assembly Committee · Health · Sponsor Patrick Burke
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7832--A
2023-2024 Regular Sessions
IN SENATE
December 20, 2023
Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when printed to be committed to the Committee on Rules -- recommitted to the Committee on Health in accordance with Senate Rule 6, sec. 8 -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to establishing a psilocybin assisted therapy pilot program for veterans and first responders
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 3309-c to read as follows:
§ 3309-c. Psilocybin assisted therapy pilot program. 1. For the purposes of this section, the following terms shall have the following meanings:
(a) "Certified medical use" includes use of medical psilocybin for a patient to treat or alleviate a patient's medical condition or symptoms associated with the patient's medical condition.
(b) "Facilitator" shall mean a mental health counselor, psychoanalyst, psychologist, physician, physician assistant, registered professional nurse, clinical nurse specialist, nurse practitioner, occupational therapist, occupational therapy assistant, licensed clinical social worker, or an individual with evidence of prior experience and knowledge in the field of psychedelic assisted therapy who has completed all requirements under subdivision three of this section.
(c) "Medical psilocybin" shall mean psilocybin intended for a certified medical use, as determined by the department.
(d) "Psilocybin" shall mean a naturally occurring psychedelic prodrug compound produced by fungi, including but not limited to members of the genus Psilocybe. Such term shall include psilocin, the substance into which psilocybin is converted in the human body.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD13531-04-4
2. (a) The department shall establish a psilocybin assisted therapy pilot program. Such pilot program shall provide ten thousand patient participants, as described in paragraph (b) of this subdivision, with the funding necessary to receive psilocybin assisted therapy. Such pilot program shall be terminated upon the approval of psilocybin for medical use by the federal drug enforcement administration, or any successor agency.
(b) Participants in the pilot program shall include veterans and their families, first responders, retired first responders, and those suffering from cluster headaches; provided, however, that such participants reside in the western region of New York.
(c) The department shall promulgate any necessary rules and regulations for the application and distribution of any funds pursuant to this subdivision.
3. Prior to facilitating a psilocybin session, a facilitator shall complete a course as determined by the department in regulation.
4. (a) The department may provide for the analysis and evaluation of the operation of this section. The department may enter into agreements with one or more persons, not-for-profit corporations, universities or other organizations, for the performance of an evaluation of the implementation and effectiveness of this section.
(b) The department may develop, seek any necessary federal approval for, and carry out research programs relating to medical use of psilocybin. Participation in any such research program shall be voluntary on the part of facilitators, patients, and designated caregivers.
(c) No later than two years after the effective date of this section and every two years thereafter, the department shall report to the governor and the legislature on the medical use of psilocybin under this section and make appropriate recommendations.
5. (a) The provisions of this section shall take precedence over any conflicting provisions of this chapter.
(b) For the purposes of this section, medical psilocybin shall not be deemed to be a "drug" for purposes of article one hundred thirty-seven of the education law.
6. (a) Patients, practitioners and facilitators shall not be subject to arrest, prosecution, or penalty in any manner, or denied any right or privilege, including but not limited to civil penalty or disciplinary action by a business or occupational or professional licensing board or bureau, solely for the certified medical use of psilocybin or for any other action or conduct in accordance with this section.
(b) This subdivision shall not bar the enforcement of a policy prohibiting an employee from performing his or her employment duties while impaired by a controlled substance. This subdivision shall not require any person or entity to do any act that would put the person or entity in direct violation of federal law or cause it to lose a federal contract or funding.
(c) The fact that a person is a patient and/or acting in accordance with this section, shall not be a consideration in a proceeding pursuant to applicable sections of the domestic relations law, the social services law, and the family court act.
(d) (i) Certification forms and any patient information contained within a database shall be deemed exempt from public disclosure under sections eighty-seven and eighty-nine of the public officers law. Upon specific request by a patient to the department, the department shall verify the requesting patient's status as a valid patient to the patient's school or employer or other designated party, to ensure compliance with the protections afforded by this subdivision.
(ii) The name, contact information, and other information relating to facilitators registered with the department under this section shall be public information and shall be maintained on the department's website accessible to the public in searchable form. However, if a facilitator notifies the department in writing that he or she does not want his or her name and other information disclosed, such facilitator's name and other information shall thereafter not be public information or maintained on the department's website, unless such facilitator cancels the request.
(e) A person currently under parole, probation or other state or local supervision, or released on bail awaiting trial may not be punished or otherwise penalized for conduct allowed under this section.
7. The department shall promulgate any rules and regulations necessary to implement the provisions of this section.
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to establishing a psilocybin assisted therapy pilot program for veterans and first respon- ders
Purpose or general idea of bill
This bill would establish a pilot program designed to provide psilocybin assisted therapy to 10,000 respondents in order to record the treat- ment's effects on their conditions.
Summary of provisions
Section 1 creates the psilocybin assisted therapy pilot program.
Section 2 states the effective date.
Justification
Psilocybin therapy offers serious potential benefits to assist with mental health, but it suffers from a lack of substantial medical test- ing. This bill would alleviate that problem by establishing a pilot program to test psilocybin therapy's effectiveness on mental health. This bill would establish a pilot program which would provide psilocybin therapy to a set of 10,000 respondents, with priority given to veterans, first responders, and those suffering from cluster headaches. This pilot program would help record the effects of this treatment on their condi- tions in order to better understand the effects of this new therapy which promises substantial benefits.
Prior legislative history
New Bill
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.